跳至主要内容
临床试验/NCT00717171
NCT00717171终止4 期

Efficacy of the SurgiStim3 Electrical Stimulation Device in Persons Undergoing Anterior Cruciate Ligament Repair

VQ OrthoCare2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2006年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
100
试验地点
2
主要终点
pain

研究概览

简要总结

The purpose of this study is to determine whether a functional electrical stimulation device, the SurgiStim3, decreases pain, pain medications and/or edema in patients undergoing anterior cruciate ligament repair.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Agree to provide informed consent to be included within this ACL study
  • Demonstrate a continued willingness to be compliant with the parameters established under the study;
  • Have no history of drug or alcohol abuse in the last 2 years;
  • Be either a male or female adult between the ages of 18 and 64;
  • Be undergoing a surgical repair of the anterior cruciate ligament (ACL) using either a hamstring, patella tendon, Achilles tendon, or allograft procedure; and
  • Understand that there is no financial remuneration for participation in the study.

排除标准

  • Pregnant women
  • Insulin dependent diabetic patients
  • Patients with a demand type pacemaker
  • Patients who have a malignant tumor (other than basal cell epithelioma)
  • Patients with a known history of alcohol or drug abuse in the last 2 years
  • Patients who will not agree to provide informed consent to be included within this ACL study
  • Patients who demonstrate a continued unwillingness to be compliant with the parameters established under this study.
  • "Poor healers" as identified by the patient's medical history
  • Patients who have a history of sensitivity to surgical tape, electrode adhesives, etc.
  • Patients with a known history of RSD (reflex sympathetic dystrophy)
  • Patients with a history of chronic pain (on opiates or high dosage of NSAIDS for 3 months or greater)
  • Patients who have previously undergone an ACL reconstruction on the same knee
  • Patients with clinically varicose veins (clinically significant or symptomatic)
  • Patients whose history shows an abuse of diuretics or anti-inflammatory medications
  • Patients who will undergo multiple ligament surgery (i.e., ACL plus PCL, MCL, and/or LCL)

结局指标

主要结局

pain

时间窗: post-op days 1, 3, 5, 7, 14, 21, 28, 35, 42

次要结局

  • pain medications(post-op days 1, 3, 5, 7, 14, 21, 28, 35, 42)
  • edema(post-op days 7, 14, 21, 28, 35, 42)

研究者

发起方
VQ OrthoCare
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验